PharmaEngine (4162) — Free Cash Flow Generation Index

Latest as of September 2025: 1.00x

PharmaEngine (4162) has a Free Cash Flow Generation Index of 1.00x as of September 2025. Free cash flow of NT$52.90 Million represents 1% of operating cash flow (NT$53.01 Million). Read PharmaEngine balance sheet liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x
Free Cash Flow / Operating CF

Free Cash Flow

NT$52.90 Million
TWD

Operating Cash Flow

NT$53.01 Million
TWD

Capital Expenditures

NT$115.00K
TWD

PharmaEngine Free Cash Flow Generation Index (2011–2024)

Historical FCF Generation Index trend for PharmaEngine across 12 annual periods. Explore capital reinvestment ratio of PharmaEngine to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for PharmaEngine (2011–2024)

Year-by-year Free Cash Flow Generation Index for PharmaEngine. For the full company profile including market capitalisation, see 4162 market cap.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2024 1.00x NT$455.32 Million NT$456.73 Million NT$1.42 Million ▲ +0.1%
2023 1.00x NT$256.01 Million NT$256.97 Million NT$958.00K ▲ +1.6%
2022 0.98x NT$198.07 Million NT$202.01 Million NT$3.94 Million ▼ -1.9%
2021 1.00x NT$929.44 Million NT$929.67 Million NT$229.00K ▲ +0.9%
2020 0.99x NT$64.16 Million NT$64.77 Million NT$608.00K ▲ +0.4%
2019 0.99x NT$15.87 Million NT$16.08 Million NT$208.00K ▼ -1.2%
2018 1.00x NT$744.72 Million NT$745.23 Million NT$510.00K ▲ +0.1%
2016 1.00x NT$869.24 Million NT$870.38 Million NT$1.15 Million ▲ +2.6%
2015 0.97x NT$436.19 Million NT$447.99 Million NT$11.80 Million ▼ -2.6%
2014 1.00x NT$130.99 Million NT$131.09 Million NT$95.00K ▲ +0.0%
2012 1.00x NT$68.56 Million NT$68.64 Million NT$83.00K ▲ +0.2%
2011 1.00x NT$274.68 Million NT$275.49 Million NT$806.00K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).